265 related articles for article (PubMed ID: 16706984)
1. von Willebrand factor mediates platelet spreading through glycoprotein Ib and alpha(IIb)beta3 in the presence of botrocetin and ristocetin, respectively.
McCarty OJ; Calaminus SD; Berndt MC; Machesky LM; Watson SP
J Thromb Haemost; 2006 Jun; 4(6):1367-78. PubMed ID: 16706984
[TBL] [Abstract][Full Text] [Related]
2. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin alphaIIbbeta3) in von Willebrand factor-induced signal transduction.
Yuan Y; Dopheide SM; Ivanidis C; Salem HH; Jackson SP
J Biol Chem; 1997 Aug; 272(35):21847-54. PubMed ID: 9268316
[TBL] [Abstract][Full Text] [Related]
3. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation.
Delaney MK; Liu J; Zheng Y; Berndt MC; Du X
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2761-8. PubMed ID: 22995516
[TBL] [Abstract][Full Text] [Related]
4. The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets.
Liu J; Pestina TI; Berndt MC; Steward SA; Jackson CW; Gartner TK
J Thromb Haemost; 2004 Dec; 2(12):2213-22. PubMed ID: 15613029
[TBL] [Abstract][Full Text] [Related]
5. Botrocetin/VWF-induced signaling through GPIb-IX-V produces TxA2 in an alphaIIbbeta3- and aggregation-independent manner.
Liu J; Pestina TI; Berndt MC; Jackson CW; Gartner TK
Blood; 2005 Oct; 106(8):2750-6. PubMed ID: 15985541
[TBL] [Abstract][Full Text] [Related]
6. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
[TBL] [Abstract][Full Text] [Related]
8. Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors.
Kasirer-Friede A; Cozzi MR; Mazzucato M; De Marco L; Ruggeri ZM; Shattil SJ
Blood; 2004 May; 103(9):3403-11. PubMed ID: 14726383
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide inhibits von Willebrand factor-mediated platelet adhesion and spreading through regulation of integrin alpha(IIb)beta(3) and myosin light chain.
Roberts W; Michno A; Aburima A; Naseem KM
J Thromb Haemost; 2009 Dec; 7(12):2106-15. PubMed ID: 19765213
[TBL] [Abstract][Full Text] [Related]
10. Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3).
Yap CL; Anderson KE; Hughan SC; Dopheide SM; Salem HH; Jackson SP
Blood; 2002 Jan; 99(1):151-8. PubMed ID: 11756165
[TBL] [Abstract][Full Text] [Related]
11. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
[TBL] [Abstract][Full Text] [Related]
12. Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination.
Matsui T; Hori A; Hamako J; Matsushita F; Ozeki Y; Sakurai Y; Hayakawa M; Matsumoto M; Fujimura Y
J Thromb Haemost; 2017 Mar; 15(3):538-548. PubMed ID: 28071872
[TBL] [Abstract][Full Text] [Related]
13. Extracellular signal-regulated kinase 5 associates with casein kinase II to regulate GPIb-IX-mediated platelet activation via the PTEN/PI3K/Akt pathway.
Cheng Z; Gao W; Fan X; Chen X; Mei H; Liu J; Luo X; Hu Y
J Thromb Haemost; 2017 Aug; 15(8):1679-1688. PubMed ID: 28603902
[TBL] [Abstract][Full Text] [Related]
14. The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation.
Yin H; Stojanovic A; Hay N; Du X
Blood; 2008 Jan; 111(2):658-65. PubMed ID: 17914025
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor.
Depraetere H; Ajzenberg N; Girma JP; Lacombe C; Meyer D; Deckmyn H; Baruch D
Blood; 1998 May; 91(10):3792-9. PubMed ID: 9573016
[TBL] [Abstract][Full Text] [Related]
16. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
[TBL] [Abstract][Full Text] [Related]
17. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
[TBL] [Abstract][Full Text] [Related]
18. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
Lei X; Reheman A; Hou Y; Zhou H; Wang Y; Marshall AH; Liang C; Dai X; Li BX; Vanhoorelbeke K; Ni H
Thromb Haemost; 2014 Feb; 111(2):279-89. PubMed ID: 24172860
[TBL] [Abstract][Full Text] [Related]
19. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
[TBL] [Abstract][Full Text] [Related]
20. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
Obert B; Houllier A; Meyer D; Girma JP
Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
